American journal of clinical oncology
-
Am. J. Clin. Oncol. · Jun 2017
Differences in Funding Sources of Phase III Oncology Clinical Trials by Treatment Modality and Cancer Type.
Given the limited resources available to conduct clinical trials, it is important to understand how trial sponsorship differs among different therapeutic modalities and cancer types and to consider the ramifications of these differences. ⋯ RCTs studying targeted therapies are more likely to be funded by industry than trials studying multimodality therapy or radiation. The impact of industry funding versus institutional or governmental sources of funding for cancer research is unclear and requires further study.